MedPath

Butalbital and Acetaminophen

Butalbital and Acetaminophen Tablets 50 mg/300 mg

Approved
Approval ID

a24ccca7-e347-44e4-b700-1cc54c525bd3

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 13, 2020

Manufacturers
FDA

LGM Pharma Solutions, LLC

DUNS: 117549198

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Butalbital and Acetaminophen

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code79739-7075
Application NumberANDA090956
Product Classification
M
Marketing Category
C73584
G
Generic Name
Butalbital and Acetaminophen
Product Specifications
Route of AdministrationORAL
Effective DateAugust 13, 2020
FDA Product Classification

INGREDIENTS (2)

ACETAMINOPHENActive
Quantity: 300 mg in 1 1
Code: 362O9ITL9D
Classification: ACTIB
BUTALBITALActive
Quantity: 50 mg in 1 1
Code: KHS0AZ4JVK
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Butalbital and Acetaminophen - FDA Drug Approval Details